TMS and Fear Extinction

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Post-traumatic Stress Disorder
  • Age: Between 18 - 70 Years
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. For Healthy Participants:
      • No significant current/past psychiatric diagnosis
      • Willing and able to provide informed consent

You may not be eligible for this study if the following are true:

    1. History of seizure or significant head trauma (i.e., extended loss of consciousness, neurological sequelae, or known structural brain lesion) or other significant neurologic disease (e.g., tic disorder)
    2. Significant psychiatric diagnosis
    3. Current significant suicidal ideation, plan or intent or suicidal behavior in past 6 months or Self-injurious behavior that involves suicidal intent, requires medical attention, or occurs daily
    4. Use of psychotropic medication within 4 weeks prior to study (within 6 weeks for fluoxetine, or other long-lived compounds; within one year for neuroleptics)
    5. Current substance use (assessed by urine test)
    6. Pregnancy (to be ruled out by urine test)
    7. Metallic implants or devices contraindicating magnetic resonance imaging
    8. Currently taking medications that lower the seizure threshold. These include antipsychotics, high dose theophylline or stimulants such as methylphenidate. Patients taking bupropion must be on a stable dose (last 3 months) and take less than or equal to 300 mg/day
    9. Implanted devices in subject's head (shunts, cochlear implants); metal in subject's head (other than dental implants)



If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.